_________
false
אופקו הלת', אינק
2
380
OPKO HEALTH, INC
Corporation no:
2279206
10802
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
11/05/2019
www.isa.gov.il
www.tase.co.il
Reference:
2019-02-044851
Time of broadcast:
19:01
18:57:05
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.
Delay the publication of a report
_________
_________
1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.
2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
שינויי החזקה בחברת Cocrystal Pharma, Inc.
20190511CocrystalSigned.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ GSM
Date of revision of form structure:
30/04/2019
Address:
Ashlegan
16
,
Kiryat Gat
8211804
Israel
,
Tel:
08-9300051
,
Fax:
08-9300091
E-mail address:
yphilip@opko.com
Company site:
Www.Opko.Com
Previous names of reporting entity:
Name of the Signatory:
Philip Yifat
Position of Signatory in the reporting corporation:
General Counsel
Name of Employer Company:
Address:
Golda Meir
7
,
Nes Ziona
7414002
Telephone:
08-9300051
Facsimile:
08-9300091
E-mail:
yphilip@opko.com
1